Voyager Therapeutics Inc (VYGR) — Cash Flow Quality Index
Voyager Therapeutics Inc (VYGR) has a Cash Flow Quality Index of -0.42x as of December 2023. Operating cash flow of $-23.76 Million is below net income of $56.40 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore VYGR long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Voyager Therapeutics Inc Cash Flow Quality Index (2020–2023)
Historical Cash Flow Quality Index for Voyager Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check VYGR tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Voyager Therapeutics Inc (2020–2023)
Year-by-year earnings quality comparison for Voyager Therapeutics Inc. For live market cap and the full company financial profile, see how much is Voyager Therapeutics Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.59x | $77.92 Million | $132.33 Million | ▲ +122.4% |
| 2020 | -2.63x | $-96.72 Million | $36.74 Million | — |